Half-year report · HY
7681.TEDINET S100Y3O3
Period2025-10-01 → 2026-03-31
Filed2026-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.3bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥21.5bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥527m | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥497m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥508m | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥309m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥514m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥508m | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥514m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥236m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥153m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥344m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥248m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥356m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥26.6bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥10.9bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥16.1bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥20.7bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.1bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥5.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.8bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.0bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.6bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.5bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.9bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥87m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥87m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.8bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥620m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥123m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥4.7bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥101m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥105m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥39.82 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.86 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.32 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥25.76 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥58.08 | 2024-10-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 21.6% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.8% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.0% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-10-01 → 2026-03-31 | ¥892m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-10-01 → 2026-03-31 | ¥886m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-10-01 → 2026-03-31 | ¥19m |
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥8m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥8m |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥60m |
| Minimally Invasive Medical Device Sales Business Reportable Segment Memberreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥10.2bn |
| Minimally Invasive Medical Device Sales Business Reportable Segment Memberreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥10.2bn |
| Minimally Invasive Medical Device Sales Business Reportable Segment Memberreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥1m |
| Minimally Invasive Medical Device Sales Business Reportable Segment Memberreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥184m |
| Remote Image Diagnosis Service Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥412m |
| Remote Image Diagnosis Service Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥412m |
| Remote Image Diagnosis Service Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥42m |
| Rental Business Reportable Segment Memberreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥318m |
| Rental Business Reportable Segment Memberreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥317m |
| Rental Business Reportable Segment Memberreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥611,000 |
| Rental Business Reportable Segment Memberreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥37m |
| Total Medical Solution Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥12.5bn |
| Total Medical Solution Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥12.5bn |
| Total Medical Solution Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥305m |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥23.4bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥23.4bn |
| —segment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥2m |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | ¥568m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-10-01 → 2026-03-31 | ¥24.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-10-01 → 2026-03-31 | ¥24.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥8m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-10-01 → 2026-03-31 | ¥587m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-10-01 → 2025-03-31 | ¥193m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-10-01 → 2025-03-31 | ¥193m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-10-01 → 2025-03-31 | ¥2m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | ¥1m |
| Remote Image Diagnosis Service Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥410m |
| Remote Image Diagnosis Service Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥410m |
| Remote Image Diagnosis Service Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥41m |
| Total Medical Solution Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥12.3bn |
| Total Medical Solution Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥12.3bn |
| Total Medical Solution Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥453m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥12.7bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥12.7bn |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥494m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥496m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 547
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities | Prior1YearInstant | 5050042000 | JPY |
| Liabilities | InterimInstant | 20653145000 | JPY |
| Capital stock | Prior1YearInstant | 545975000 | JPY |
| Capital stock | InterimInstant | 545975000 | JPY |
| Capital surplus | Prior1YearInstant | 505551000 | JPY |
| Capital surplus | InterimInstant | 518403000 | JPY |
| Retained earnings | Prior1YearInstant | 4508263000 | JPY |
| Retained earnings | InterimInstant | 4625765000 | JPY |
| Treasury stock | Prior1YearInstant | -166000 | JPY |
| Treasury stock | InterimInstant | -166000 | JPY |
| Shareholders equity | Prior1YearInstant | 5559623000 | JPY |
| Shareholders equity | InterimInstant | 5689978000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 75224000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 45196000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 75224000 | JPY |
| Valuation and translation adjustments | InterimInstant | 45196000 | JPY |
| Non controlling interests | Prior1YearInstant | 184511000 | JPY |
| Non controlling interests | InterimInstant | 189677000 | JPY |
| Net assets | Prior1YearInstant | 5819360000 | JPY |
| Net assets | InterimInstant | 5924852000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 10869403000 | JPY |
| Liabilities and net assets | InterimInstant | 26577997000 | JPY |
| Net sales | Prior1InterimDuration | 12940317000 | JPY |
| Net sales | InterimDuration | 24280794000 | JPY |
| Cost of sales | Prior1InterimDuration | 11279275000 | JPY |
| Cost of sales | InterimDuration | 21153495000 | JPY |
| Gross profit | Prior1InterimDuration | 1661041000 | JPY |
| Gross profit | InterimDuration | 3127298000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 1164166000 | JPY |
| Selling general and administrative expenses | InterimDuration | 2600363000 | JPY |
| Operating income | Prior1InterimDuration | 496875000 | JPY |
| Operating income | InterimDuration | 526935000 | JPY |
| Interest income noi | Prior1InterimDuration | 2146000 | JPY |
| Interest income noi | InterimDuration | 3438000 | JPY |
| Dividends income noi | Prior1InterimDuration | － | JPY |
| Dividends income noi | InterimDuration | 1869000 | JPY |
| Insurance premiums refunded cancellation noi | Prior1InterimDuration | 14023000 | JPY |
| Insurance premiums refunded cancellation noi | InterimDuration | 7050000 | JPY |
| Dividends income of insurance noi | Prior1InterimDuration | 420000 | JPY |
| Dividends income of insurance noi | InterimDuration | 381000 | JPY |
| Purchase discounts noi | Prior1InterimDuration | － | JPY |
| Purchase discounts noi | InterimDuration | 2191000 | JPY |
| Gain on sales of investment securities noi | Prior1InterimDuration | － | JPY |
| Gain on sales of investment securities noi | InterimDuration | 7336000 | JPY |
| Subsidy income noi bounty | Prior1InterimDuration | 885000 | JPY |
| Subsidy income noi bounty | InterimDuration | 650000 | JPY |
| Other noi | Prior1InterimDuration | 1930000 | JPY |
| Other noi | InterimDuration | 3679000 | JPY |
| Non operating income | Prior1InterimDuration | 19406000 | JPY |
| Non operating income | InterimDuration | 26596000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |